when do you increase semaglutide dose How to Restart New to GLP1s: is this

STEP 1 Clinical Trial Data (Wegovy): Study population: 1,961 adults with obesity or overweight plus weight-related conditions Duration: 68 weeks Average weight loss: 14.9% of body weight Results distribution: 86% lost at least 5% body weight

Abegg, K

GLP-1RA can induce glucose-dependent stimulation of insulin secretion, reduce glucagon release, reduce hepatic glucose output, delay gastric emptying and increase satiety, resulting in moderate reductions in glycated hemoglobin (HbA1c), body weight and systolic blood pressure, the risk of hypoglycemia is lower

It ferments more slowly than some other fibers, resulting in less gas and bloatingsymptoms that can be exacerbated when taking GLP-1 medications